New clinical trial registered for Carfilzomib

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma (NCT07479979) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.